Raf Hofstein

Raf Hofstein

Director/Miembro de la Junta en SCOPUS BIOPHARMA INC. .

Fortuna: - $ al 31/08/2026

77 años
Health Technology
Commercial Services
Finance

Perfil

Raphael Hofstein is the founder of Israel Tech Transfer Organization.
Dr. Hofstein is currently Chief Executive Officer & Director at Triphase Accelerator Corp., Chairman at Clinical Trials Ontario, Encycle Therapeutics, Inc., and Notch Therapeutics, Inc. Dr. Hofstein is an Independent Director at BioLineRx Ltd. since 2003, Director at Cell Cure Neurosciences Ltd., Life Sciences Ontario, Dynamic Memory Medical Technologies Ltd., Terheuer Ltd., Bedside Clinical Systems, Inc., Accel-Rx, and Director at Scopus Biopharma, Inc. since 2022.
Formerly, Dr. Hofstein was Chairman, President & Chief Executive Officer at Hadasit Medical Research Services & Development Ltd. from 2000 to 2009, President, Chief Executive Officer & Director at Toronto Innovation Acceleration Partners from 2009 to 2020, President & Chief Executive Officer at Xagenic, Inc., Chairman at Fibrocor Therapeutics, Inc., Co-Chairman at LifeBond Ltd., Chairman at HBL- Hadasit Bio-Holdings Ltd. in 2005, Chairman of the Board at Hadasit Bio-Holdings Ltd. from 2010 to 2015, Chairman at KAHR Medical Ltd., Director-Business Unit at Ecogen, Inc., Director at Forticell Bioscience, Inc. from 2006 to 2008, Director at ConjuGate Ltd., Director at Evogene Ltd. from 2000 to 2012, Director at Thrombotech Ltd., TK-Signal Ltd., ProtAb Ltd., Verto Medical Ltd., Bio-MarCare Technologies Ltd., Centre For Commercialization of Regenerative Medicine, G.V.T Ltd., QD Solar, Inc., Independent Director at Scopus Biopharma, Inc. from 2020 to 2022, President at Mindsense Biosystems Ltd., and Manager-Research & Development at International Genetic Science Partnership.
Education includes undergraduate degree from The Hebrew University of Jerusalem in 1974, graduate degree from Weizmann Institute of Science in 1975, and doctorate from Weizmann Institute of Science in 1980.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/03/2026 0 ( -.--% ) - $ 31/08/2026

Cargos activos de Raf Hofstein

EmpresasCargoInicio
BIOLINERX LTD. Director/Miembro de la Junta 01/01/2003
SCOPUS BIOPHARMA INC. Director/Miembro de la Junta 28/04/2022
Dynamic Memory Medical Technologies Ltd.
Director/Miembro de la Junta -
Terheuer Ltd.
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Presidente -
Director/Miembro de la Junta -
Presidente -
Director/Miembro de la Junta -
░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ -
░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ -

Antiguos cargos conocidos de Raf Hofstein.

EmpresasCargoFin
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Raf Hofstein.

Formación de Raf Hofstein.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

77

Relaciones de 1er grado

37

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas37

Process Industries

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Finance

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Mindsense Biosystems Ltd.

Health Services

Health Technology

Commercial Services

Health Technology

Dynamic Memory Medical Technologies Ltd.

Commercial Services

Terheuer Ltd.

Technology Services

Commercial Services

Finance

Health Technology

Health Technology

Electronic Technology

Commercial Services

Health Technology

Health Technology

Health Technology

International Genetic Science Partnership

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN